The FDA has granted approval to the age-related macular degeneration treatment Eylea, clearing the way to provide another form of treatment for the leading eye disease causing blindness in the … [Read more...]
Macular Degeneration Drugs
October 20, 2011 By 1 Comment
With age-related macular degeneration recognized as the leading cause of blindness in the aging population, developing drugs to combat the eye disease has become a priority for many pharmaceutical … [Read more...]
Gene Therapy and Stem Cell Therapy for Macular Degeneration
September 23, 2011 By 1 Comment
Macular Degeneration has been identified as a leading cause of blindness and vision loss among older people. Because of better diagnostic techniques in recent years, more and more people are being … [Read more...]
Eylea Treatment for Macular Degeneration
August 23, 2011 By 3 Comments
A new drug has been developed as a treatment for macular degeneration. The drug named Eylea will compete directly with Lucentis, the current leading treatment for the eye disease. It is expected … [Read more...]
Gene Based Macular Degeneration Treatment Promising
August 2, 2011 By Leave a Comment
A new gene based treatment for wet macular degeneration has showed promise after being administered to 18 patients as part of an ongoing study. Developed by Oxford Biomedica, RetinoStat targets … [Read more...]
Recent Comments